Research progress of epigenetics therapy for lung cancer / 中国肿瘤临床
Chinese Journal of Clinical Oncology
;
(24): 1570-1572, 2013.
Artigo
em Chinês
| WPRIM
| ID: wpr-439760
ABSTRACT
The five-year survival rate of lung cancer, one of the cancers with higher morbidity and death rate, is less than 15%. Studies have shown that the occurrence of lung cancer is related to many factors in which epigenetics is an important one. In recent years, with the successful clinical application of epigenetic therapy drugs such as methylation transferase and histone deacetylase inhibi-tors that can enhance the sensitivity of chemotherapy, epigenetics has become a research hotspot. This paper briefly introduces the re-search progress in DNA methylation, acetylation, and cancer chemotherapy sensitivity in lung cancer diagnosis and treatment.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Journal of Clinical Oncology
Ano de publicação:
2013
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS